Related Experiment Video
Updated: Oct 13, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction
1Department of General Medicine, Gunma University School of Medicine, Maebashi, Japan.
Insights
Interleukin-6 (IL-6) and its receptors are elevated in acute myocardial infarction patients, correlating with cardiac dysfunction markers. This finding may explain IL-6
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Interleukin-6 (IL-6) is a proinflammatory cytokine implicated in coronary artery disease (CAD) pathogenesis.
- Understanding the role of IL-6 and its receptors in CAD is crucial for disease management.
Purpose of the Study:
- To investigate circulating levels of IL-6 and its receptors (IL-6R alpha and IL-6R beta) in patients with CAD.
- To explore the relationship between IL-6, its receptors, and cardiac dysfunction markers in CAD patients.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure plasma levels of IL-6, IL-6R alpha, and IL-6R beta in 39 CAD patients and 15 controls.
- Blood samples were collected at multiple time points over 5 days.
- Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) levels were measured.
Main Results:
- Plasma levels of IL-6 and IL-6Rs were significantly increased in patients with acute myocardial infarction (AMI) compared to controls.
- No significant increase in IL-6 or IL-6Rs was observed in patients with angina pectoris.
- Two peaks of circulating IL-6 were observed in AMI patients, with the first peak correlating with ANP and BNP levels.
Conclusions:
- Elevated IL-6 and IL-6 receptor levels are associated with AMI.
- The findings suggest a link between IL-6 production and myocardial dysfunction severity in CAD.
- IL-6 may serve as a potential biomarker for assessing CAD severity and patient outcomes.
Abstract:
Interleukin-6 (IL-6), a proinflammatory cytokine, plays a key role in the pathogenesis of coronary artery disease (CAD). We investigated circulating IL-6 and its receptors in patients with CAD. We evaluated 39 Japanese patients with CAD (30 males and 9 females aged 36-79 years), measuring their plasma levels of IL-6 and IL-6 receptors alpha and beta (IL-6R alpha, IL-6R beta). Circulating levels of IL-6, IL-6R alpha and IL-6R beta were measured by an enzyme-linked immunosorbent assay. Blood was sampled immediately after admission and again after 1, 2, 3, 6 and 9 h, then every 12 h for 5 days. Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were measured on day 3 after symptom onset. Plasma levels of IL-6 and IL-6Rs were significantly increased in 28 patients with acute myocardial infarction (AMI) compared with 15 normal controls. However, neither IL-6 nor IL-6Rs showed an increase in 6 patients with angina pectoris. We observed two peaks for circulating IL-6 in AMI, the first of which showed a significant correlation with ANP as well as BNP. These results may help to explain why the amount of IL-6 produced is closely related to the severity of myocardial dysfunction in patients with CAD.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
